Gaze - Análise Fundamentalista

Gaze – Market Intelligence in the Palm of Your Hand
Stop reacting to the market. Start anticipating it.

Gaze transforms official data from Brazil and the US into visual patterns and AI-generated insights — so you can invest with clarity, not guesswork.

MACRO SECTOR RADAR
See in real time which sectors are receiving positive or negative signals from the main official US sources: FRED, BLS, EIA, CFTC, FDA, Census and more. The heatmap crosses sector × source and reveals where trends converge — before the market prices it in.

COMPANY RADAR
AI applied to official documents (CVM, SEC) to highlight the most relevant events of each company: relevant facts, buybacks, results and much more — with automatic classification of positive or negative impact.

STOCK RANKING
Score from 0 to 100 calculated from profitability, margins, growth and valuation. Filter by country and sector and find companies with the best fundamentals in seconds.

ANALYSTS & TARGET PRICE
Consolidated recommendation trends (Strong Buy, Buy, Hold, Sell), monthly valuation history, and 12-month average target price with High/Medium/Low ranges — all in a single visual chart.

DIVIDEND RANKING
Find the stocks with the highest dividend yield, payment history for the last 5 years, frequency, and date of the last payment. Ideal for those living off passive income.

FUNDAMENTAL SCREENERS
Filter the market by ROE, ROIC, Net Margin, and other key indicators. Discover opportunities that others haven't seen yet.

BIGGEST MOVES
Track the biggest gains and losses of the day in Brazil and the US, plus the most traded stocks of the week — all updated in real time.

COMPLETE FINANCIAL HEALTH
Balance Sheet, Income Statement, Cash Flow Statement and market indicators (P/E, P/BV, Beta) for over 2,000 global assets, with interactive charts and historical comparison.

REAL-TIME MARKET

Dollar, Euro, Ibovespa, S&P 500 and much more — right on the home screen.

PLANS
Monthly: R$ 34.90
Annual: R$ 251.28 — save 40%

Gaze does not offer investment recommendations. The data and analyses are for informational purposes only.